Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Carcieri

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Pharmacology & Physiology|July 27, 2017
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in childrenSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
Pharmacogenomics|June 20, 2018
Pharmacogenetic of voriconazole antifungal agent in pediatric patientsSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
British Journal of Clinical Pharmacology|August 15, 2017
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in childrenSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 9, 2017
Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestationsLucio Boglione, Amedeo De Nicolò, Simone Mornese Pinna, et al.
Recenti Progressi in Medicina|November 17, 2024
Chiara Carcieri, Silvia Scalpello, Agnese Bosio, et al.
Pharmacogenomics|April 29, 2017
Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patientsJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.
Biomedicines|November 22, 2017
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal InfectionSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
Pharmacogenomics|May 24, 2018
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapyJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 17, 2018
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patientsJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2018
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary studyJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Pharmacology & Physiology|July 27, 2017
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in childrenSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
Pharmacogenomics|June 20, 2018
Pharmacogenetic of voriconazole antifungal agent in pediatric patientsSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
British Journal of Clinical Pharmacology|August 15, 2017
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in childrenSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 9, 2017
Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestationsLucio Boglione, Amedeo De Nicolò, Simone Mornese Pinna, et al.
Recenti Progressi in Medicina|November 17, 2024
Chiara Carcieri, Silvia Scalpello, Agnese Bosio, et al.
Pharmacogenomics|April 29, 2017
Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patientsJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.
Biomedicines|November 22, 2017
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal InfectionSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
Pharmacogenomics|May 24, 2018
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapyJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 17, 2018
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patientsJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2018
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary studyJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
Pageof 3